期刊文献+

结肠癌患者血清中microRNA-183及胸苷激酶1的表达及意义 被引量:11

The expression and significance of serum microRNA-183 and TK1 in patients with colorectal cancer
下载PDF
导出
摘要 目的检测结肠癌患者血清中mi RNA-183及胸苷激酶1(TK1)的表达并探讨其临床意义。方法收集结肠癌患者及健康体检者血清标本各52例,荧光定量PCR检测mi RNA-183表达,免疫印迹增强化学发光法检测TK1的表达,分析两者之间的相关性及与临床病理的关系。结果与正常对照组相比,结肠癌患者血清mi R-183的表达相对升高(P<0.01);中低分化腺癌者血清mi R-183的表达量高于高分化腺癌(P<0.01);Ⅲ~Ⅳ期结肠癌者血清中mi R-183的表达量高于Ⅰ~Ⅱ期(P<0.01),且在有淋巴结转移的患者中表达较高(P<0.01);受试者工作特征(ROC)曲线显示,以相对表达量1.15为临界点,血清mi R-183可能具有诊断结肠癌的价值,其敏感度为78.8%,特异度为67.3%,阳性预测值为78.9%,阴性预测值为70.2%。结肠癌患者血清中TK1的表达也较正常对照组升高,中低分化腺癌高于高分化腺癌(P<0.05),Ⅲ~Ⅳ期高于Ⅰ~Ⅱ期(P<0.01)。血清中mi R-183与TK1的表达呈正相关(rs=0.692,P<0.01)。结论血清中mi R-183及TK1可能是早期结肠癌的诊断标志物,并可用于判断肿瘤的恶性程度及预后。 Objective To detect the expression and significance of serum miRNA- 183 and TK1 in patients withcolorectal cancer, and the mechanism thereof. Methods Fifty-two serum samples of colorectal cancer patients and pairedhealth serum samples were collected. The expression of miRNA-183 was detected by real-time quantitative PCR, and TK1 was detected by Western blot enhanced chemiluminescence assay. The correlation between miRNA-183 and TK1 and theirrelations with the clinicpathologic characteristics were analyzed. Results The serum miRNA- 183 expression wassignificantly higher in colorectal cancer group than that in normal control group(P 〈 0.01). The expression of serum miRNA-183 was significantly higher in stage Ⅲ-Ⅳ group than that in stage Ⅰ-Ⅱ group(P 〈 0.01). There was more significantincrease in serum miRNA- 183 in lymphatic metastasis group than that without lymphatic metastasis group(P 〈 0.01).Receiver operating characteristic(ROC) curve showed that of there was a diagnostic value for serum miRNA- 183 incolorectal cancer, with an optimal value of 1.15. The diagnostic sensitivity and specificity were 78.8% and 67.3%, and thepositive predictive value and negative predictive value were 78.9% and 70.2%. The serum TK1 expression was also higher incolorectal cancer group compared with that of normal control group(P 〈 0.01). And the TK1 expression was also higher instage Ⅲ-Ⅳ group than that in stage Ⅰ-Ⅱ group(P 〈 0.01). Furthermore, miRNA-183 expression was positively correlatedwith TK1 expression(rs=0.692, P 〈 0.01). Conclusion The serum expression levels of mi R-183 and TK1 may act as tumormarkers for early colorectal cancer diagnosis, and also can be used to predict the malignant degree and prognosis ofcolorectal cancer.
出处 《天津医药》 CAS 2017年第1期72-75,共4页 Tianjin Medical Journal
关键词 结肠肿瘤 微RNAS 胸苷激酶 血清 结肠癌 miRNA-183 colonic neoplasms micro RNAs thymidine kinase serum colon cancer miR-183
  • 相关文献

参考文献5

二级参考文献69

  • 1顾光大.血清胃蛋白酶原、胸苷激酶联合检测对胃癌的诊断意义[J].实用医学杂志,2009,25(5):715-717. 被引量:14
  • 2CHEN Hong1,CHEN Qun2,FANG Ming3 & MI Yan1 1 The First Affiliated Hospital of Harbin Medical University,Harbin 150101,China,2 Harbin Acheng District People’s Hospital,Harbin 150300,China,3 Graduate Department of Harbin Medical University,Harbin 150001,China.microRNA-181b targets MLK2 in HL-60 cells[J].Science China(Life Sciences),2010,53(1):101-106. 被引量:20
  • 3李连弟,陈育德.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社.2008. 被引量:5
  • 4陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12. 被引量:144
  • 5赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25. 被引量:197
  • 6Cho WC. OncomiRs: the discovery and progress of mi-croRNAs in cancers[J]. Mol Cancer, 2007,6 .. 60-65. 被引量:1
  • 7Gabriely G, Wurdinger T, Kesari S, et al. MicroRNA 21 pro- motes glioma invasion by targeting matrix metalloproteinase regulators[J]. Mol Cell Biol, 2008,28 (17) : 5369-5380. 被引量:1
  • 8Wang R,Wang ZX,Yang JS,et al. MieroRNA-451 func- tions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)[J]. Oncogene, 2011,30(23) : 2644-2658. 被引量:1
  • 9Kent OA,Chivukula RR, Mullendore M, et al. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway[J]. Genes Dev, 2010,24(24) .. 2754-2759. 被引量:1
  • 10Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, ieu- covorin, and oxaliplatin(FOLFOX4) versus FOLFOX4 a- lone as first-line treatment in patients with previously un- treated metastatic colorectal cancer: the PRIME study[J]. J Clin Oncol,2010,28(31) :4697-4705. 被引量:1

共引文献210

同被引文献123

引证文献11

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部